Complementarily, IGF-1R preferentially activates IRS-2 [120] as it was found that IRS-2 contains a KLRB domain that functions to block the tyrosine kinase domain in the cytoplasmic region of the IR, and that such does not happen in the IGF-1R
Published research compares NAC, oral glutathione, and sublingual glutathione head-to-head (Schmitt et al., 2015)
While current retail "GLP-1 patches" are herbal supplements, pharmaceutical researchers are actively working on true transdermal delivery of peptide drugs and some of this work shows real promise
The peptide is useful in comparisons between single-, dual-, and triple-agonist strategies across various endpoints: Food Intake and Appetite Regulation Energy Expenditure and Substrate Utilization Glucose Pathway Regulation and Insulin Secretion Dynamics Lipid Handling and Metabolic Flexibility Retatrutide also provides a structured context for research into dose-response relationships, safety monitoring, and the durability of metabolic changes
However, beyond appetite suppression and improved insulin secretion, emerging evidence suggests these agents may influence gut motility, microbial diversity, and inflammatory signaling